Abstract:
A device which supports identification of an integrated display and dynamic adjustments to operating parameters thereof includes: a port that receive a test strip having a reaction site for receiving a sample of fluid from a patient, a blood glucose (bG) meter cooperatively operable with a test strip inserted in the port to measure glucose in a sample of fluid on the test strip, and a display device having an electrically resistive component integrated therein and operable to display the glucose measurement in accordance with one or more operating parameters associated with the display device The system also includes a monitoring module electrically connected to the resistive component, wherein the monitoring module determines a type for the display device based on a resistance of the resistive component and a control module that selectively adjusts a given operating parameter of the display device in accordance with the type of display device.

Description:
FIELD 
     The present disclosure relates to a medical device and a system and method for detecting a type of a display integrated with in the medical device, and in particular for adjusting operating parameters of the display device based on the display type. 
     BACKGROUND 
     Medical devices are often used as diagnostic devices and/or therapeutic devices in diagnosing and/or treating medical conditions of patients. For example, a blood glucose meter is used as a diagnostic device to measure blood glucose (bG) levels of patients suffering from diabetes. An insulin infusion pump is used as a therapeutic device to administer insulin to patients suffering from diabetes. 
     In the treatment of the patient, a patient may use a handheld bG meter to measure his or her bG measurements. The patient may rely on these bG measurements to make treatment decisions, e.g., whether or not to take insulin and if so, how much insulin to take. The bG meter includes an integrated display device. The bG meter communicates with the display device in order to display medical data such as a bG measurement or an instruction to provide a blood sample. In order to ensure a consistent perceived appearance of the display device, the display device may be adjusted based on display parameters associated with a display type of the display device. Accordingly, a system and method for detecting the display type of the display device and for adjusting the display parameters of the display device is desired. 
     The background description provided herein is for the purpose of generally presenting the context of the disclosure. Work of the presently named inventors, to the extent it is described in this background section, as well as aspects of the description that may not otherwise qualify as prior art at the time of filing, are neither expressly nor impliedly admitted as prior art against the present disclosure. 
     SUMMARY 
     A handheld medical device which supports identification of an integrated display and dynamic adjustments to operating parameters thereof includes a port configured to receive a test strip having a reaction site for receiving a sample of fluid from a patient. The system further includes a blood glucose (bG) meter cooperatively operable with a test strip inserted in the port to measure glucose in a sample of fluid residing on the test strip and a display device having an electrically resistive component integrated therein and operable to display the glucose measurement in accordance with one or more operating parameters associated with the display device The system also includes a monitoring module electrically connected to the resistive component, wherein the monitoring module operates to determine a resistance of the electrically resistive component and a type for the display device based on the resistance and a control module in data communication with the display device and the monitoring module, wherein the control module selectively adjusts a given operating parameter of the display device in accordance with the type of display device. 
     A method for identification of an integrated display and dynamic adjustments to operating parameters thereof, includes: receiving a test strip having a reaction site for receiving a sample of fluid from a patient; measuring glucose in a sample of fluid residing on the test strip; displaying the glucose measurement in accordance with one or more operating parameters associated with a display device; determining a resistance of an electrically resistive component integrated within the display device and a type for the display device based on the resistance; and selectively adjusting a given operating parameter of the display device in accordance with the type of display device. 
     Further areas of applicability of the present disclosure will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the disclosure. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         FIG. 1  shows a patient and a treating clinician; 
         FIG. 2  shows a patient with a continuous glucose monitor (CGM), ambulatory durable insulin infusion pump, ambulatory non-durable insulin infusion pump, and a diabetes manager in accordance with various embodiments of the present disclosure; 
         FIG. 3  shows a diabetes care system of systems used by patients and clinicians to manage diabetes in accordance with various embodiments of the present disclosure; 
         FIG. 4  shows a block diagram illustrating example components of a medical device and a mobile device according to various embodiments of the present disclosure; 
         FIG. 5A  shows an example configuration of a monitoring module that determines a type of display of a display device according to various embodiments of the present disclosure; 
         FIG. 5B  shows an alternative configuration of a monitoring module that determines a type of display device according to the various embodiments of the present disclosure; and 
         FIG. 6  shows a flow chart illustrating an exemplary method for dynamically adjusting an integrated display according to various embodiments of the present disclosure. 
     
    
    
     Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings. The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure. 
     DETAILED DESCRIPTION 
     Referring now to  FIG. 1 , a patient  100  with diabetes and a clinician  102  are shown in a clinical environment. Persons with diabetes include persons with metabolic syndrome, pre-diabetes, type 1 diabetics, type 2 diabetics, and gestational diabetics and are collectively referred to as a patient. Healthcare providers for diabetes are diverse and include nurses, nurse practitioners, physicians, and endocrinologists and are collectively referred to as a clinician. 
     During a healthcare consultation, the patient  100  typically shares with the clinician  102  a variety of patient data including blood glucose (bG) measurements, continuous glucose monitor data, amounts of insulin infused, amounts of food and beverages consumed, exercise schedules, and other lifestyle information. The clinician  102  may obtain additional patient data that includes measurements of HbA1C, cholesterol levels, triglycerides, blood pressure, and weight of the patient  100 . The patient data can be recorded manually or electronically on a handheld diabetes management device  104 , a diabetes analysis software executed on a personal computer (PC)  106 , and/or a web-based diabetes analysis site (not shown). The clinician  102  can analyze the patient data manually or electronically using the diabetes analysis software and/or the web-based diabetes analysis site. After analyzing the patient data and reviewing adherence of the patient  100  to previously prescribed therapy, the clinician  102  can decide whether to modify the therapy for the patient  100 . 
     Referring now to  FIG. 2 , the patient  100  can use a continuous glucose monitor (CGM)  200 , an ambulatory durable insulin infusion pump  202  or an ambulatory non-durable insulin infusion pump  204  (collectively insulin pump  202  or  204 ), and the handheld diabetes management device  104  (hereinafter the diabetes manager  104 ). The CGM  200  uses a subcutaneous sensor to sense and monitor the amount of glucose in the blood of the patient  100  and communicates corresponding readings to the diabetes manager  104 . 
     The diabetes manager  104  performs various tasks including measuring and recording blood glucose levels, determining an amount of insulin to be administered to the patient  100  via the insulin pump  202  or  204 , receiving patient data via a user interface, archiving the patient data, etc. The diabetes manager  104  periodically receives readings from the CGM  200  indicating insulin level in the blood of the patient  100 . The diabetes manager  104  transmits instructions to the insulin pump  202  or  204 , which delivers insulin to the patient  100 . Insulin can be delivered in the form of a bolus dose, which raises the amount of insulin in the blood of the patient  100  by a predetermined amount. Additionally, insulin can be delivered in a scheduled manner in the form of a basal dose, which maintains a predetermined insulin level in the blood of the patient  100 . 
     Referring now to  FIG. 3 , a diabetes management system  300  used by the patient  100  and the clinician  102  includes one or more of the following devices: the diabetes manager  104 , the continuous glucose monitor (CGM)  200 , the insulin pump  202  or  204 , a mobile device  302 , the diabetes analysis software on the PC  106 , and other healthcare devices  304 . The diabetes manager  104  is configured as a system hub and communicates with the devices of the diabetes management system  300 . Alternatively, the insulin pump  204  or the mobile device  302  can serve as the system hub. Communication between the various devices in the diabetes management system  300  can be performed using wireless interfaces (e.g., Bluetooth) and/or wireline interfaces (e.g., USB). Communication protocols used by these devices can include but are not limited to protocols compliant with the IEEE 11073 standard as extended using guidelines provided by Continua® Health Alliance Design Guidelines. Further, healthcare records systems such as Microsoft® HealthVault™ can be used by the patient  100  and clinician  102  to exchange information. 
     The diabetes manager  104  can receive blood glucose readings from one or more sources (e.g., from the CGM  200 ). The CGM  200  continuously measures the blood glucose level of the patient  100 . The CGM  200  periodically communicates the blood glucose level to the diabetes manager  104 . The diabetes manager  104  and the CGM  200  communicate wirelessly using, for example, a proprietary Gazell wireless protocol developed by Nordic Semiconductor, Inc. 
     Additionally, the diabetes manager  104  includes a blood glucose meter (BGM) and a port that communicates with the BGM (both not shown). The port can receive a blood glucose measurement strip  306 . The patient  100  deposits a sample of blood or other bodily fluid on the blood glucose measurement strip  306 . The BGM analyzes the sample and measures the blood glucose level in the sample. The blood glucose level measured from the sample and/or the blood glucose level read by the CGM  200  can be used to determine the amount of insulin to be administered to the patient  100 . 
     The diabetes manager  104  communicates with the insulin pump  202  or  204 . The insulin pump  202  or  204  can be configured to receive instructions from the diabetes manager  104  to deliver a predetermined amount of insulin to the patient  100 . Additionally, the insulin pump  202  or  204  can receive other information including meal and/or exercise schedules of the patient  100 . The insulin pump  202  or  204  can determine the amount of insulin to administer based on the additional information. 
     The insulin pump  202  or  204  can also communicate data to the diabetes manager  104 . The data can include amounts of insulin delivered to the patient  100 , corresponding times of delivery, and pump status. The diabetes manager  104  and the insulin pump  202  or  204  can communicate using a wireless communication protocol such as Bluetooth. Other wireless or wireline communication protocols can also be used. 
     In addition, the diabetes manager  104  can communicate with other healthcare devices  304 . For example, the other healthcare devices  304  can include a blood pressure meter, a weight scale, a pedometer, a fingertip pulse oximeter, a thermometer, etc. The other healthcare devices  304  obtain and communicate personal health information of the patient  100  to the diabetes manager  104  through wireless, USB, or other interfaces. The other healthcare devices  304  use communication protocols compliant with ISO/IEEE 11073 extended using guidelines from Continua® Health Alliance. The diabetes manager  104  can communicate with the other healthcare devices  304  using interfaces including Bluetooth, USB, etc. Further, the devices of the diabetes management system  300  can communicate with each other via the diabetes manager  104 . 
     The diabetes manager  104  can communicate with the PC  106  using Bluetooth, USB, or other interfaces. A diabetes management software running on the PC  106  includes an analyzer-configurator that stores configuration information of the devices of the diabetes management system  300 . The configurator has a database to store configuration information of the diabetes manager  104  and the other devices. The configurator can communicate with users through standard web or computer screens in non-web applications. The configurator transmits user-approved configurations to the devices of the diabetes management system  300 . The analyzer retrieves data from the diabetes manager  104 , stores the data in a database, and outputs analysis results through standard web pages or computer screens in non-web based applications. 
     The diabetes manager  104  can communicate with the mobile device  302  using Bluetooth. The mobile device  302  may include a cellular phone, a PDA, or a pager. The diabetes manager  104  can send messages to an external network through the mobile device  302 . The mobile device  302  can transmit messages to the external network based on requests received from the diabetes manager  104 . 
     Referring now to  FIG. 4 , a medical device  400  in communication with mobile device  302  is illustrated. For purposes of explanation, it is assumed that the medical device  400  and the mobile device  302  are paired devices, such that communication between the medical device  400  and the mobile device  302  is enabled. In the illustrative example, the medical device  400  is a diabetes manager  104  (as shown  FIGS. 1 ,  2 , and  3 ) and includes a control module  402 , a display device  404 , a monitoring module  406 , a communication interface  408 , and a bG meter  410 . In the example embodiment, the medical device  400  is configured to determine an electrical resistance of a resistive component integrated within the display device  404  to determine a display type of the display device  404 . 
     The monitoring module  406  communicates the display type to the control module  402 . In the illustrative embodiment, the mobile device  302  includes a slave application  420 , a display device  422 , and a communication interface  424 . It is appreciated that the medical device  400  and the mobile device  302  include additional components that are not shown and the components described herein are provided for example and are not intended to be exhaustive. 
     As mentioned above, in the illustrative example the medical device  400  is a diabetes manager  104 . Thus, the medical device  400  includes the bG meter  410 . The bG meter  410  receives a bG measurement strip  306  ( FIG. 3 ), which the patient doses with a blood sample, and determines a bG measurement based on blood sample. The bG measurement is provided to the control module  402  for display on the display device  404 . 
     The control module  402  is configured to control the operation of the medical device  400 . The control module  402  can determine when a patient is to be prompted to provide a blood sample, perform structured testing, determine any corrective actions that may be taken based on a bG reading, and/or perform any other suitable tasks. Further, the control module  402  is configured to display medical data on the display device  404 . In the case of a diabetes manager  104 , the control module  402  can provide medical data, e.g., bG measurements determined by the bG meter  410  or instructions to the patient for providing a blood sample, for display by the display device  404 . 
     The display device  404  can be any device capable of electronically displaying data. The display device  404  is integrated within the medical device  400  such that a screen of the display device  404  is located at a front surface of the medical device  400 . In some embodiments, the display device  404  is a touchscreen that displays data and can detect the presence of a touch within the display area. In these embodiments, the display device  404  can be a capacitive touchscreen, an infrared touchscreen, resistive touchscreen, or any other type of touchscreen. In other embodiments the display device  404  is an LCD display. The medical device  400  may also include a user interface (not shown) such as a keyboard or physical buttons. The display device  404  may also include a display cache (not shown) which caches information that is to be displayed by the display device  404 . 
     The display device  404  includes an electrically conductive loop  602  as shown in  FIG. 5A . In the exemplary embodiment, the conductive loop  602  is integrated along a peripheral edge of a screen  600 . The conductive loop  602  may be a thin wire made from indium tin oxide. It should be appreciated that the conductive loop  602  can be made from any other suitable conductive material which can be formed into a thin wire. In the case of an LCD display or a touchscreen display, the conductive loop  602  can be integrated along the peripheral edge of a glass or plastic panel of the screen  600 . 
     The monitoring module  406  is electrically coupled to the conductive loop  602  at a first end  604  of the conductive loop  602  and at a second end  606  of the conductive loop  602 . In operation, the monitoring module  406  determines a resistance of the conductive loop  602 . For example, the monitoring module  406  applies a predetermined voltage to the conductive loop  602 . The monitoring module  406  measures a current flowing from the first end  604  to the second end  606 . The monitoring module  406  then determines a resistance value between the first end  604  and the second end  606  based on the applied voltage and the measured current. For example, the monitoring module  406  applies Ohm&#39;s Law in order to mathematically determine the resistance between the first end  604  and the second end  606 . In other words, the resistance is equal to the applied voltage divided by the measured current. 
     In the exemplary embodiment, the monitoring module  406  determines the display type of the display device  404 . For example, the display device  404  may be one of a plurality of display devices. Each of the plurality of display devices is designed to be integrated into the medical device  400 . During assembly of the medical device  400 , one of the plurality of display devices is integrated into the medical device  400 . Each of the plurality of display devices is configured to meet a predefined display standard. The predefined display standard is designed to ensure each of the plurality of display devices is capable of operably functioning as the display device  404 . 
     Each of the plurality of display devices is manufactured by one of a predetermined plurality of manufacturers. For example, a first display device of the plurality of display devices may be manufactured by a first manufacturer; whereas, a second display device of the plurality of display devices may be manufactured by a second manufacturer. It is understood that a single manufacturer may manufacture one or more of the plurality of display devices. By way of non-limiting example, a third manufacturer may manufacture a third display device, a fourth display device, and a fifth display device. Each of the plurality of display devices has an associated display type. For example, the first display device may be a first display type. Similarly, the second display device may be a second display type. It is understood that the first display type and differ from the second display type. For example, the first display type may include a first color contrast value. Whereas the second display type may include a second color contrast value. It is further understood that that each of display types may be a color display or a black and white display. 
     Each display type is a type of display device associated with a manufacturer. For example, the first display type may be manufactured by the first manufacture. It is understood that a signal manufacturer may manufacture one or more display types. The display type associated with a particular display device may be identifiable based on a resistance of an electrically conductive loop integrated within the particular display device. Each manufacturer of the plurality of display devices is assigned one or more predetermined conductive loop resistance values. 
     In one embodiment, the predetermined resistance value is assigned by the manufacturer of the medical device  400 . In one example, a first manufacturer is assigned a first conductive loop resistance value and a second conductive loop resistance value. The first manufacturer manufactures a first type of display device. The first type of display device is manufactured to include a first electrically conductive loop. The first manufacturer configures the electrical properties of the first electrically conductive loop to have a resistance equal to the first conductive loop resistance value. 
     The first manufacturer may also manufacture a second type of display device. The second type of display device is manufactured to include a second electrically conductive loop. The first manufacture configures the electrical properties of the second electrically conductive loop to have resistance equal to the second conductive loop resistance value. 
     The monitoring module  406  determines the display type of the display device  404  based on a measured resistance of the conductive loop  602 . For example, the monitoring module  406  measures the resistance between the first end  604  and the second end  606 . The monitoring module  406  compares the measured resistance value to a list of predefined resistances values. For example, the list of predefined resistances may be a look-up table of resistance values. Each predefined resistance value is an entry in the list of predefined resistances. Each entry in the list of predefined resistances may include a plurality of associated fields as will be described in detail below. Each of the predefined resistance values correspond to a display type. The monitoring module  406  determines the display type associated with the measured resistance value. In this way, the monitoring module  406  determines the display type of the display device  404 . 
     In some implementations, the monitoring module  406  determines the display type of the display device  404  when the medical device  400  is powered on. For example, the monitoring module  406  determines the display type as described above each time the medical device  400  is turned on. In another implementation, the monitoring module  406  stores a display type value in an associated memory. When the medical device  400  is powered on, the monitoring module  406  reads the display type value stored in the associated memory in order to determine the display type of the display device  404 . 
     With particular reference to  FIG. 5B , an alternative configuration of the display device  404  includes a resistor  608 . The resistor  608  may be a passive two terminal resistor or any other suitable electrical resistor. It is further understood that the resistor  608  may be a plurality of resistors electrically coupled to achieve a desired combined resistance. The monitoring module  406  is electrically coupled to the resistor  608  at a first end  604 B of the resistor  608  and at a second end  606 B of the resistor  608 . In operation, the monitoring module  406  determines a resistance of the resistor  608 . The monitoring module  406  applies a predetermined voltage to the resistor  608 . The monitoring module  406  measures a current flowing from the first end  604 B to the second end  606 B. The monitoring module  406  then determines a resistance value between the first end  604 B and the second end  606 B based on the applied voltage and the measured current. For example, the monitoring module  406  applies Ohm&#39;s Law in order to mathematically determine the resistance between the first end  604 B and the second end  606 B. In other words, the resistance is equal to the applied voltage divided by the measured current. 
     In the exemplary embodiment, the monitoring module  406  determines the display type of the display device  404  as described with respect to  FIG. 5A . For example, the display device  404  may be one of the plurality of display devices. Each of the plurality of display devices is designed to be integrated into the medical device  400 . During assembly of the medical device  400 , one of the plurality of display devices is integrated into the medical device  400 . Each of the plurality of display devices is configured to meet a predefined display standard. The predefined display standard is designed to ensure each of the plurality of display devices is capable of operably functioning as the display device  404 . 
     Each of the plurality of display devices is manufactured by one of the predetermined plurality of manufacturers. For example, a first display device of the plurality of display devices may be manufactured by a first manufacturer; whereas, a second display device of the plurality of display devices may be manufactured by a second manufacturer. It is understood that a single manufacturer may manufacture one or more of the plurality of display devices. By way of non-limiting example, a third manufacturer may manufacture a third display device, a fourth display device, and a fifth display device. Each of the plurality of display devices has an associated display type. For example, the first display device may be a first display type. Similarly, the second display device may be a second display type. It is understood that the first display type and differ from the second display type. For example, the first display type may include a first color contrast value. Whereas the second display type may include a second color contrast value. It is further understood that that each of display types may be a color display or a black and white display. 
     Each display type is a type of display device associated with a manufacturer. For example, the first display type may be manufactured by the first manufacture. It is understood that a signal manufacturer may manufacture one or more display types. The display type associated with a particular display device may be identifiable based on a resistance of resistor integrated within the particular display device. Each manufacturer of the plurality of display devices is assigned one or more predetermined resistance values. 
     In one embodiment, the predetermined resistance value is assigned by the manufacturer of the medical device  400 . In one example, a first manufacturer is assigned a first resistance value and a second resistance value. The first manufacturer manufactures a first type of display device. The first type of display device is manufactured to include a first resistor. The first manufacturer may select the first resistor to have a resistance equal to the first resistance value. Alternatively, the first manufacture may select a plurality of resistors to have a combined resistance equal to the first resistance value. 
     The first manufacturer may also manufacture a second type of display device. The second type of display device is manufactured to include a second resistor. The first manufacture configures may select the second resistor to have resistance equal to the second resistance value. Alternatively, the first manufacture may select a plurality of resistors to have a combined resistance equal to the second resistance value. 
     The monitoring module  406  determines the display type of the display device  404  based on a measured resistance of the resistor  608 . For example, the monitoring module  406  measures the resistance between the first end  604 B and the second end  606 B. The monitoring module  406  compares the measured resistance value to a list of predefined resistances values. For example, the list of predefined resistances may be a look-up table of resistance values. Each predefined resistance value is an entry in the list of predefined resistances. Each entry in the list of predefined resistances may include a plurality of associated fields as will be described in detail below. Each of the predefined resistance values correspond to a display type. The monitoring module  406  determines the display type associated with the measured resistance value. In this way, the monitoring module  406  determines the display type of the display device  404 . 
     The display device  404  includes dynamically adjustable operating parameters. For example, brightness, contrast, gray scale, flicker, and tint may be adjusted in order to change the perceived appearance of the display device  404 . It is understood that while only a limited number of adjustable operating parameters of the display device  404  are described, the display device  404  may include any other suitable adjustable operating parameter. 
     Due to variances in manufacturing processes and materials used to manufacture the plurality of display devices, the dynamically adjustable operating parameters of the display device  404  may be selectively adjusted in order to alter the perceived appearance of the display device  404 . In this way, a display device integrated within a first instance of the medical device  400  has a consistent perceived appearance with that of a display device integrated within a second instance of the medical device  400 . For example, the monitoring module  406  determines the display type of the display device  404  as previously discussed. Each entry in the list of predefined resistances includes a predefined resistance and an associated display type. For example, a first resistance is associated with a first display type. Each entry in the list of predefined resistances also includes an associated predefined operating parameters values set. For example, the first display type may include a corresponding first predefined operating parameter values set. 
     The monitoring module  406  determines the predefined operating parameter values corresponding to the display device  404 . For example, the measured resistance may be a resistance equivalent to the first resistance. The first resistance corresponds to the first display type. The first display type corresponds to the first predefined operating parameter values set. The first predefined operating parameter values set may include a brightness value, a contrast value, a gray scale value, and a tint value. It is understood that the first predefined operating parameter values set may include any alternative or additional suitable parameter value to those described herein. 
     The monitoring module  406  communicates the predefined operating parameter values set associated with the display device  404  to the control module  402 . The control module  402  selectively adjusts the dynamically adjustable operating parameters of the display device  404  based on the predefined operating parameter values set. For example, the monitoring module  406  communicates the first predefined operating parameter values set to the control module  402 . The control module  402  adjusts the dynamically adjustable operating parameters of the display device  404  based on the first predefined operating parameter values set. For example only, the control module  402  sets a brightness of the display device  404  equal to the brightness value of the first predefined operating parameter values set. 
     In one embodiment, the monitoring module  406  determines whether to adjust the dynamically adjustable operating parameters of the display device  404 . For example, the monitoring module  406  determines whether the operating parameters of the display device  404  are set to a default value. As described above, the monitoring module  406  determines the display type of the display device  404 . Each of the entries in the list of predefined resistances may also include an associated default operating parameter values set. For example, the first resistance corresponds to the first display type. The first display type is associated with the first predetermined operating parameters values set. Further, the first display type is associated with a first operating default parameter values set. The first default parameter values set may include a default brightness value, a default contrast value, a default gray scale value, and a default tint value. It is understood that the first default operating parameter values set may include any alternative or additional suitable parameter value to those described herein. 
     The monitoring module  406  determines a current operating parameter values set of the display device  404 . For example, the monitoring module  406  determines a current brightness value, a current gray scale value, a current contrast value, and a current tint value of the display device  404 . The monitoring module  406  then compares each of the determined current operating parameter values with each of the first default operating parameter values. When the monitoring module  406  determines the current operating parameter values are the same as the first default operating parameter values, the monitoring module  406  communicates the first predefined operating parameter values set to the control module  402 . The control module  402  then adjusts the dynamically adjustable operating parameters of the display device  404  to be equal to the first predefined operating parameter values. 
     When the monitoring module  406  determines the current operating parameter values are not the same as the first default operating parameter values, the monitoring module  406  then compares each of the determined current operating parameter values with each of the first predefined operating parameter values. When the monitoring module  406  determines the current operating parameter values are not the same as the first predefined operating parameter values, the monitoring module communicates the first predefined operating parameter values set to the control module  402 . The control module  402  then adjusts the dynamically adjustable operating parameters of the display device  404  to be equal to the first predefined operating parameter values. 
     Conversely, when the monitoring module  406  determines the current operating parameter values are the same as the first predefined operating parameter values, the monitoring module does not communicates the first predefined operating parameter values set to the control module  402 . In other words, the dynamically adjustable operating parameters of the display device  404  are adjusted to be equal to the first predefined operating parameter values set, and therefore, the control module  402  does not adjust the dynamically adjustable operating parameters of the display device  404 . 
     In another embodiment, the monitoring module  406  determines whether a user of the medical device  400  has adjusted one or more dynamically adjustable operating parameters of the display device  404 . The list of predefined resistances may include a user defined operating parameter values set. The user defined operating parameter values set may be dynamically adjustable based on input from a user. 
     For example, if the user of the medical device  400  adjusts a brightness value of the display device  404 , a brightness value of the user defined operating parameter values set may be dynamically adjusted to be equal to the brightness value set by the user. In the example embodiment, the monitoring module  406  compares each of the determined current operating parameter values with each of the user defined operating parameter values. When the monitoring module  406  determines the current operating parameter values are not the same as the user defined operating parameter values, the monitoring module communicates the user defined operating parameter values set to the control module  402 . The control module  402  then adjusts the dynamically adjustable operating parameters of the display device  404  to be equal to the user defined operating parameter values set. 
     Conversely, when the monitoring module  406  determines the current operating parameter values are the same as the user defined operating parameter values, the monitoring module does not communicates the user defined operating parameter values set to the control module  402 . In other words, the dynamically adjustable operating parameters of the display device  404  are adjusted to be equal to the user defined operating parameter values set, and therefore, the control module  402  does not adjust the dynamically adjustable operating parameter of the display device  404 . 
     In another embodiment, the monitoring module  406  determines whether to adjust the dynamically adjustable operating parameters of the display device  400  based on whether the medical device  400  is being started for the first time. For example, the medical device  400  may set a startup value within an associated memory when the medical device  400  is initially started. The startup value may be set to a factory setting. For example, the startup value may be set to 0 when the medical device  400  is assembled. The medical device  400  may be configured to set the startup value to 1 when the medical device  400  is initially started. The monitoring module  406  determines whether to adjust the dynamically adjustable operating parameters of the display device  400  based on the startup value. For example, when the startup value is 0 the monitoring module  406  determines to adjust the dynamically adjustable operating parameters. The monitoring module  406  then determines the device type associated with the display device  404  as described above. Conversely, when the startup value is 1, the monitoring module  406  determines not to adjust the dynamically adjustable operating parameters. 
     As will be discussed in greater detail below, the mobile device  302  is configured to act as a slave device of the medical device  400 . By way of non-limiting example only, the control module  402  is configured to provide commands to the mobile device  302  to display the medical data. The commands can include the medical data which is to be displayed by the mobile device  302 . Furthermore, the control module  402  can provide a command to the mobile device  302  to display a graphical user interface (GUI) to the patient such that the patient can interact with medical device  400  via a user interface of the mobile device  302 . 
     In the illustrated example, the communication interface  408  is configured to effectuate communication with one or more other devices, including the mobile device  302 . The communication interface  408  can implement any suitable communication protocol. For example, the communication interface  408  can be a Bluetooth® transceiver, an 802.11 transceiver, an infrared transceiver, or any other suitable transceiver. Alternatively, the communication interface  408  can be a wired communication interface such as a USB interface. In the illustrative embodiment, the control module  402  provides commands to the mobile device  302  via the communication interface  408 . 
     The mobile device  302  can be any suitable mobile device, including but not limited to a mobile telephone, a tablet computing device, a personal digital assistant (PDA). As should be appreciated the display device  422  of the mobile device  302  can be any suitable display, including but not limited to a touchscreen or an LCD display. 
     The mobile device  302  receives commands from the medical device  400  via the communication interface  424  of the mobile device  302 . As should be appreciated, mobile devices  302  are typically configured to support numerous different communication protocols. Thus, the communication interface  424  can include a Bluetooth® transceiver, an 802.11 transceiver, an infrared transceiver, and/or any other suitable transceiver. Alternatively, the communication interface  424  can be a wired communication interface such as a USB interface. The communication interface  424  receives commands from the medical device  400  and provides the commands to the slave application  420 . 
     In an exemplary embodiment, the slave application  420  is an application that is executed by one or more processors (not shown) on the mobile device  302 . The slave application  420  can be downloaded to and/or installed on the mobile device  302  by the patient. The slave application  420  can be provided by the manufacturer of the mobile device  302  or a third-party. In some embodiments, the slave application  420  may execute as a background process. The slave application  420  may be automatically launched or a visual notification may be displayed to the patient on the display device  422  of the mobile device  302  instructing the patient to launch the slave application  420 . Alternatively, the operating system of the mobile device  302  may be configured to receive the notification from the medical device  400  and may automatically launch the slave application  420  upon receiving the notification or may provide the visual notification to the patient instructing the patient to launch the slave application  420 . 
     Once the slave application  420  is launched, the mobile device  302  can be said to be operating in a slave mode, such that the slave application  420  is controlled at least in part by the medical device  400 . Thus, the slave application  420  receives commands from the medical device  400  and performs actions defined in the commands. Thus, the slave application  420  can include one or more GUI screens that can be displayed by the display device  422  of the mobile device  302 . For example, in some embodiments the slave application  420  can display a GUI screen that replicates a GUI displayed by the display device  404  of the medical device  400 . In these embodiments, the slave application may receive a command to display a GUI screen. In response, the slave application  420  displays the GUI screen on the display device  422  of the mobile device  302 . 
     As was discussed, the medical device  400  provides commands to the slave application  420  to display medical data. In some embodiments, the commands can include the type of medical data that is to be displayed and/or the medical data to be displayed. For example, if the medical device  400  provides a command to display a bG measurement, the command may include the value of the bG measurement as well as an indicator that the medical data is a bG measurement to be displayed. In response to the command, the slave application  420  can display a screen for displaying bG measurement values on the display device  422  and can display the received bG measurement value therein. 
     In another example, the medical device  400  may provide a command to the slave application  420  to display an instruction to the patient to provide a blood sample. In this example, the command may include the instruction to be displayed as well as an indicator that the medical data is an instruction to provide a blood sample. In response to the command, the slave application  420  can display a GUI screen that includes the instruction to provide a blood sample on the display device  422  of the mobile device  302 . It should be appreciated that an instruction to provide a blood sample includes any technique for collecting a blood sample, including but not limited to, prompting the patient to insert a blood strip and to dose the blood strip with the blood sample after insertion, and prompting the patient to insert an already dosed blood sample. Furthermore, in some embodiments the displayed GUI screen may include a visual button where the patient can verify that the patient has provided the blood sample, e.g., the patient has inserted a blood glucose measurement strip  306  in the bG meter  410 . If the patient presses the visual button, the slave application  420  can transmit a verification indicating that the patient has provided the blood sample to the medical device  400  via the communication interface  424 . 
     The foregoing examples are provided to illustrate the types of medical data that the slave application  420  can display on the display device  422  of the mobile device  302  and are not intended to be limiting. It should be appreciated that the slave application  420  can be configured to display other types of medical data depending on the type of medical device  400 . For instance, if the medical device  400  is a blood pressure machine the medical data that is displayed may relate to a blood pressure measurement. Furthermore, the mobile device  302  may receive commands from the medical device  400  to display additional information, such as an instruction to contact the medical device  400  manufacturer and a phone number of the medical device  400  manufacturer. In these embodiments, the patient may call the medical device  400  manufacturer to quickly obtain a replacement medical device  400  or a replacement part. 
     Further, it is appreciated that while  FIG. 4  depicts a mobile device  302 , the slave application  420  can be implemented on any suitable device that can execute the slave application  420  and has a display device  422  and a communication interface  424 , such that the medical device  400  can be paired with the device executing the slave application  420 . For example, the slave application  420  may be executed by a personal computer or a television. 
     With particular reference to  FIG. 6 , a flow diagram depicting an example method for determining a display type of the display device  404  begins at  700 . At  704 , the method  700  determines whether to adjust the dynamically adjustable parameters of the display device  404 . In one embodiment, the monitoring module  406  determines whether to adjust the dynamically adjustable operating parameters of the display device  404  based on the startup value as described above. For example, when the startup value is 0, the monitoring module  406  determines the medical device  400  is being started for the first time. When the medical device  400  is started for the first time, the monitoring module  406  determines to adjust the dynamically adjustable operating parameters of the display device  404 . At  708 , the method  700  determines a resistance value of a resistive component integrated within the display device  404 . For example, the monitoring module  406  determines a resistance between the first end  604  and the second end  606 . 
     At  712 , the monitoring module  406  compares the measured resistance value with a look-up table of predetermined resistance values. At  716 , the monitoring module  406  determines a display type of the display device  404 . The monitoring module  406  determines a predetermine resistance value corresponding to the measured resistance value. The predetermined resistance value is associated with a first device type. The first device type corresponds to the device type of the display device  404 . At  720 , the method  700  determines a predefined operating parameter values set associated with the display type. For example, each of the predetermined resistance values has an associated device type, as described above. The associated device type has an associated predefined operating parameter values set. The monitoring module  406  determines the predefined operating parameter values set associated with the first display type. At  724 , the control module  402  selectively adjusts dynamically adjustable operating parameters of the display device  404  based on the predefined operating parameter values set. At  728 , the method  700  receives a test strip. The test strip includes a blood sample from a patient. The patient may insert the test strip into a port integrated within the medical device  400 . The port is arranged to receive the test strip and the blood sample from the patient. At  732 , the method  700  measures a glucose value present in the blood sample included with the test strip. At  736 , the method  700  displays the glucose measurement on the display device  404 . The method  700  ends at  740 . 
     As used herein, the term module may refer to, be part of, or include an Application Specific Integrated Circuit (ASIC); an electronic circuit; a combinational logic circuit; a field programmable gate array (FPGA); a processor (shared, dedicated, or group) that executes code; other suitable components that provide the described functionality; or a combination of some or all of the above, such as in a system-on-chip. The term module may include memory (shared, dedicated, or group) that stores code executed by the processor. 
     The term code, as used above, may include software, firmware, and/or microcode, and may refer to programs, routines, functions, classes, and/or objects. The term shared, as used above, means that some or all code from multiple modules may be executed using a single (shared) processor. In addition, some or all code from multiple modules may be stored by a single (shared) memory. The term group, as used above, means that some or all code from a single module may be executed using a group of processors. In addition, some or all code from a single module may be stored using a group of memories. 
     The apparatuses and methods described herein may be implemented by one or more computer programs executed by one or more processors. The computer programs include processor-executable instructions that are stored on a non-transitory tangible computer readable medium. The computer programs may also include stored data. Non-limiting examples of the non-transitory tangible computer readable medium are nonvolatile memory, magnetic storage, and optical storage.